165 related articles for article (PubMed ID: 19020542)
1. BCR/ABL induces chromosomal instability after genotoxic stress and alters the cell death threshold.
Dierov J; Sanchez PV; Burke BA; Padilla-Nash H; Putt ME; Ried T; Carroll M
Leukemia; 2009 Feb; 23(2):279-86. PubMed ID: 19020542
[TBL] [Abstract][Full Text] [Related]
2. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
[TBL] [Abstract][Full Text] [Related]
3. BCR/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair.
Cramer K; Nieborowska-Skorska M; Koptyra M; Slupianek A; Penserga ET; Eaves CJ; Aulitzky W; Skorski T
Cancer Res; 2008 Sep; 68(17):6884-8. PubMed ID: 18757400
[TBL] [Abstract][Full Text] [Related]
4. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells.
Poplawski T; Blasiak J
Mol Biol Rep; 2010 Jun; 37(5):2309-15. PubMed ID: 19697154
[TBL] [Abstract][Full Text] [Related]
5. Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells.
Valeri A; Alonso-Ferrero ME; Río P; Pujol MR; Casado JA; Pérez L; Jacome A; Agirre X; Calasanz MJ; Hanenberg H; Surrallés J; Prosper F; Albella B; Bueren JA
PLoS One; 2010 Dec; 5(12):e15525. PubMed ID: 21203397
[TBL] [Abstract][Full Text] [Related]
6. Leukemia patient-derived lymphoblastoid cell lines exhibit increased induction of leukemia-associated transcripts following high-dose irradiation.
Spencer A; Granter N
Exp Hematol; 1999 Sep; 27(9):1397-401. PubMed ID: 10480430
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL stimulates mutagenic homologous DNA double-strand break repair via the DNA-end-processing factor CtIP.
Salles D; Mencalha AL; Ireno IC; Wiesmüller L; Abdelhay E
Carcinogenesis; 2011 Jan; 32(1):27-34. PubMed ID: 20974687
[TBL] [Abstract][Full Text] [Related]
8. Imatinib (ST1571) provides only limited selectivity for CML cells and treatment might be complicated by silent BCR-ABL genes.
Jiang G; Yang F; Li M; Weissbecker K; Price S; Kim KC; La Russa VF; Safah H; Ehrlich M
Cancer Biol Ther; 2003; 2(1):103-8. PubMed ID: 12673129
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Roger R; Issaad C; Pallardy M; Léglise MC; Turhan AG; Bertoglio J; Bréard J
Blood; 1996 Feb; 87(3):1113-22. PubMed ID: 8562937
[TBL] [Abstract][Full Text] [Related]
10. BCR/ABL, DNA damage and DNA repair: implications for new treatment concepts.
Skorski T
Leuk Lymphoma; 2008 Apr; 49(4):610-4. PubMed ID: 18398719
[TBL] [Abstract][Full Text] [Related]
11. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
Chu S; McDonald T; Bhatia R
Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
[TBL] [Abstract][Full Text] [Related]
12. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM
Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172
[TBL] [Abstract][Full Text] [Related]
13. BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint.
Dierov J; Dierova R; Carroll M
Cancer Cell; 2004 Mar; 5(3):275-85. PubMed ID: 15050919
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
Sallmyr A; Tomkinson AE; Rassool FV
Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
[TBL] [Abstract][Full Text] [Related]
15. BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response.
Griaud F; Williamson AJ; Taylor S; Potier DN; Spooncer E; Pierce A; Whetton AD
J Proteomics; 2012 Dec; 77():14-26. PubMed ID: 22705319
[TBL] [Abstract][Full Text] [Related]
16. BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells.
Slupianek A; Nowicki MO; Koptyra M; Skorski T
DNA Repair (Amst); 2006 Feb; 5(2):243-50. PubMed ID: 16297667
[TBL] [Abstract][Full Text] [Related]
17. A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector.
Zhao RC; Jiang Y; Verfaillie CM
Blood; 2001 Apr; 97(8):2406-12. PubMed ID: 11290604
[TBL] [Abstract][Full Text] [Related]
18. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells.
Buckle AM; Mottram R; Pierce A; Lucas GS; Russell N; Miyan JA; Whetton AD
Mol Med; 2000 Oct; 6(10):892-902. PubMed ID: 11126203
[TBL] [Abstract][Full Text] [Related]
19. Constitutive 53BP1/γH2AX foci are increased in cells of ALL patients dependent on BCR-ABL and TEL-AML1 preleukemic gene fusions.
Somsedikova A; Markova E; Kolenova A; Puskacova J; Kubes M; Belyaev I
Neoplasma; 2014; 61(5):617-25. PubMed ID: 25244981
[TBL] [Abstract][Full Text] [Related]
20. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
